Merck MRK
NYSE MRK
$146.63 -2.13 (-1.43%)
As of: Nov 10, 2026 · 12:49 PM EST

Merck (MRK) EBIT Margin (2009 - 2026)

Updated

Merck's EBIT Margin came in at -3.52% for Q2 2026, down 35.10 percentage points from 31.58% a year earlier but up 17.34 percentage points from the prior quarter.

Analysis

Merck (MRK) EBIT Margin (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Merck reported EBIT Margin of 9.58%, down 20.42 percentage points year-over-year; for FY2025, it came in at 32.64%, up 1.61 percentage points from FY2024.

  • EBIT Margin carries a five-year change of +20.66 percentage points (FY2020 to FY2025).
  • Going back by year, EBIT Margin was 31.03% in FY2024 (-23.67 pp), 54.71% in FY2023 (+24.44 pp), 30.27% in FY2022 (+4.53 pp) and 25.74% in FY2021 (+13.77 pp).
  • The five-year range for quarterly EBIT Margin is -34.34% (Q2 2023) to 37.79% (Q1 2025).
  • Year-over-year, EBIT Margin has declined for three consecutive quarters, with an average year-over-year change of -10.91 percentage points over the last eight quarters.
  • The fastest year-over-year change in EBIT Margin over five years came in Q2 2024 (a gain of 71.88 percentage points), and the weakest in Q2 2023 (a drop of 68.09 percentage points).
  • Business Quant data shows MRK's EBIT Margin at -20.85% (Q1 2026), 23.49% (Q4 2025) and 37.66% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 52.42%
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 24.35%
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 36.01%
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 30.89%
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 32.97%
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 20.57%
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 35.79%
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 41.71%
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 32.98%
10 Vertex Pharmaceuticals 138.78 Bn 110.77 Bn 2.91 Bn 20.72%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 30.89%
Jun 30, 2026 -3.52%
Mar 31, 2026 -20.85%
Dec 31, 2025 23.49%
Sep 30, 2025 37.66%
Jun 30, 2025 31.58%
Mar 31, 2025 37.79%
Dec 31, 2024 27.50%
Sep 30, 2024 23.58%
Jun 30, 2024 37.54%
Mar 31, 2024 35.73%
Dec 31, 2023 14.76%
Sep 30, 2023 36.00%
Jun 30, 2023 -34.34%
Mar 31, 2023 25.81%
Dec 31, 2022 24.86%
Sep 30, 2022 26.82%
Jun 30, 2022 33.75%
Mar 31, 2022 35.02%
Dec 31, 2021 26.44%
API Access

Merck EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=MRK&period=max&api_key=YOUR_API_KEY